/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

M

Melissa Bersanelli

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

357

Papers

4.8K

Citations

34

h-index

103

i10-index

Melissa Bersanelli is an academic researcher. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Diabetes Treatment and Management & Renal cell carcinoma treatment. The author has an h-index of 34, co-authored 304 publications.

ORCID: 0000-0002-6527-6281

Research Topics

Cancer Immunotherapy and Biomarkers Diabetes Treatment and Management Renal cell carcinoma treatment Pancreatic and Hepatic Oncology Research Cancer Genomics and Diagnostics

Papers by this author

works

A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable

2019 · Journal for ImmunoTherapy of Cancer · 400 citations

https://doi.org/10.1186/s40425-019-0527-y

Alessio Cortellini Melissa Bersanelli Sebastiano Buti Katia Cannita

Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours

2023 · Journal of Hepatology · 57 citations

https://doi.org/10.1016/j.jhep.2023.10.040

Ciro Celsa Giuseppe Cabibbo Claudia Angela Maria Fulgenzi Bernhard Scheiner

Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts

2017 · Journal of Translational Medicine · 43 citations

https://doi.org/10.1186/s12967-016-1095-2

Vera Hirsh Sandro Pignata Melissa Bersanelli Letizia Gnetti

Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients

2019 · Scientific Reports · 27 citations

https://doi.org/10.1038/s41598-019-49250-6

Sebastiano Buti Pierre I. Karakiewicz Melissa Bersanelli Umberto Capitanio

Three-Dimensional Deep Noninvasive Radiomics for the Prediction of Disease Control in Patients With Metastatic Urothelial Carcinoma treated With Immunotherapy

2021 · Clinical Genitourinary Cancer · 20 citations

https://doi.org/10.1016/j.clgc.2021.03.012

Francesco Rundo Melissa Bersanelli Valeria Urzia Alex Friedlaender

Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study

2023 · Cancer Immunology Immunotherapy · 16 citations

https://doi.org/10.1007/s00262-023-03522-3

Melissa Bersanelli Alessio Cortellini Alessandro Leonetti Alessandro Parisi

Research topics

topics

Cancer Immunotherapy and Biomarkers

Diabetes Treatment and Management

Renal cell carcinoma treatment

Pancreatic and Hepatic Oncology Research

Cancer Genomics and Diagnostics

Chat about Author

Papers

Chat

Click to start Chat